HUM Stock Summary and Trading Ideas (Humana | NYSE:HUM)

Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Humana trades on the NYSE stock market under the symbol HUM.

As of August 4, 2026, HUM stock price declined to $362.16 with 1,148,535 million shares trading.

HUM has a beta of 0.91, meaning it tends to be less sensitive to market movements. HUM has a correlation of 0.04 to the broad based SPY ETF.

HUM has a market cap of $43.48 billion. This is considered a Large Cap stock.

Last quarter Humana reported $41 billion in Revenue and $7.61 earnings per share. This beat revenue expectation by $310 million and exceeded earnings estimates by $.80.

In the last 3 years, HUM traded as high as $530.54 and as low as $163.11.

The top ETF exchange traded funds that HUM belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.

HUM has outperformed the market in the last year with a return of +47.9%, while the SPY ETF gained +25.3%. In the last 3 month period, HUM beat the market returning +55.4%, while SPY returned +7.3%. However, in the most recent 2 weeks HUM has underperformed the stock market by returning -9.1%, while SPY returned +3.9%.

HUM support price is $364.79 and resistance is $384.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HUM shares will trade within this expected range on the day.